Spreadex Market Update

European markets open lower following Merkel re-election.



European stock markets are seen opening slightly lower to unchanged as investors focus on developments in Germany following the re-election of Chancellor Angela Merkel. Despite Merkel winning her third term at the helm of Europe’s biggest economy, the votes came in slightly short of an overall victory. It will now be up to Merkel to convince leftist rivals to join a coalition government. The Euro initially traded higher as investors were given a sigh of relief after Merkel’s win who will likely keep German policy unchanged.

Asian stock markets traded slightly lower overnight despite better than expected Chinese factory orders which expanded for a second month in September. The preliminary HSBC Flash Manufacturing PMI rose to 51.2 after jumping the most since 2010 to 50.1 in August.

Crude remained steady overnight as developments in Syria took effect easing concerns over supply risks.  Russia’s Foreign Minister said Sunday they are ready to send a limited number of troops and observers to Syria to review chemical-weapon stockpiles.

Risers

Aberdeen Asset Management, +1.99%

Topping the list of risers within the FTSE 100, shares in Aberdeen Asset Management have soared after the firm revealed that underlying pre-tax profit for the year to 30 September 2013 is now expected to be towards the upper end of market forecasts. This comes despite assets under management dipping slightly, with £201.7bn at 31 August 2013 against 30 June 2013's count of £209.6bn. The Group announced that clients pulled £1.2bn from funds spread across asset classes in those two months. Gross new business flows for the two-month period totalled £7bn, bringing the year-to-date total to £41.3b, compared to last year's 11-month figure of £33.1bn.

Croda International, +0.93%

Croda International was upgraded by stock analysts at Credit Suisse from a “neutral” rating to an “outperform” rating in a report issued today. The firm currently has a 3,000p price target on the stock, up from their previous price target of 2,600p. Credit Suisse’s price objective points to a potential upside of 11.94% from the company’s current price.

Dechra Pharmaceuticals, +3.46%

Dechra Pharmaceuticals was upgraded by Investec to a “buy” rating in a research note issued today. The firm currently has a 788p price objective on the stock, up from their previous price objective of 708p. Investec’s price objective suggests a potential upside of 13.46% from the stock’s previous close.

Dairy Crest, +1.36%

Dairy Crest said that it continues to focus on the profitability of its key brands and its dairies business and cost reduction remains an important part of its strategy. Sales of the company’s four key brands are together likely to be broadly the same as they were in the corresponding period last year when they grew by 11% compared to the six months ended 30 September 2011. The cheese business performed well in the first half, said Dairy Crest, and it expects sales of Cathedral City to have outperformed the market and increased in the first half compared to the same period last year.

Ariana Resources, +50 %

Shares in the gold exploration and development company have added over 50 percent to their value after the company reported on “exceptional” results. from exploration work carried on the Kiziltepe Sector of the Red Rabbit Gold Project in western Turkey. It has uncovered four highly mineralised gold-silver zones within the Kepez and Karakavak prospect areas alongside a “substantially increased” number of gold-silver bearing veins mapped in the region. The exploration targets were generated from a “comprehensive data review”, Ariana said.

Fallers

Centrica, -1.42%

Centrica shares have taken a hit after the company decided not to proceed with its new-build gas storage project at Baird in the UK southern North Sea and to put its project at Caythorpe in East Yorkshire on hold indefinitely. Centrica will write off all costs incurred and committed on these projects and expects to recognise impairments and provisions totalling approximately £240m as an exceptional cost in the group's 2013 preliminary financial results.

Ferrexpo, -2.09%

Stock analysts at Citigroup Inc. cut their target price on shares of Ferrexpo from 230p to 220p in a report issued today. The firm currently has a “buy” rating on the stock. Citigroup Inc.’s price objective indicates a potential upside of 20.75% from the stock’s previous close.

Petrofac, -0.99%

Shares in Petrofac have slid despite winning huge Kazak contract in conjunction with Linde AG of Germany. The eventual scope for the IPCI petrochemical project will include the engineering, procurement, construction and commissioning of a gas plant, ethane cracker, gas pipelines, polyethylene plants and associated utilities and off-site in the Tengiz and Karabatan areas.

Dunelm Group, -1.25%

Dunelm Group’s stock had its “underperform” rating restated by Bank of America Corp. in a research note issued today. They currently have a 800p price target on the stock. Bank of America Corp.’s price target indicates a potential downside of 16.49% from the company’s current price.

Savile, -43.48%

Savile Group said it was seeking new funding and moving immediately to cut costs as its main business was hit by a big downturn in demand over the summer that hasn't improved much this month .It said it had traded profitably in the second half of its last financial year after trading improved, but the first quarter of the current financial year has seen a significant downturn in expected activity in Fairplace, its corporate transition business which represents around 70% of sales.

DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.